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Object. In evaluating pediatric patients for shunt malfunction, predictive values for symptoms and signs are impor­
tant in deciding which patients should undergo an imaging study, whereas determining clinical findings that correlate 
with a low probability of shunt failure could simplify management.
Methods. Data obtained during the recently completed Pediatric Shunt Design Trial (PSDT) were analyzed. Predic­
tive values were calculated for symptoms and signs of shunt failure. To refine predictive capability, a shunt score based 
on a cluster of signs and symptoms was derived and validated using multivariate methods.
Four hundred thirty-one patient encounters after recent shunt insertions were analyzed. For encounters that took place 
within 5 months after shunt insertion (early encounters), predictive values for symptoms and signs included the following: 
nausea and vomiting (positive predictive value [PPV] 79%, likelihood ratio [LR] 10.4), irritability (PPV 78%, LR 9.8), de­
creased level of consciousness (LOC) (PPV 100%), erythema (PPV 100%), and bulging fontanelle (PPV 92%, LR 33.1). 
Between 9 months and 2 years after shunt insertion (late encounters), only loss of developmental milestones (PPV 83%, 
LR 36.7) and decreased LOC (PPV 100%) were strongly associated with shunt failure. However, the absence of a symp­
tom or sign still left a 15 to 29% (early encounter group) or 9 to 13% (late encounter group) chance of shunt failure. Using 
the shunt score developed for early encounters, which sums from 1 to 3 points according to the specific symptoms or signs 
present, patients with scores of 0, 1, 2, and 3 or greater had shunt failure rates of 4%, 50%, 75%, and 100%, respectively. 
Using the shunt score derived from late encounters, patients with scores of 0, 1, and 2 or greater had shunt failure rates of 
8%, 38%, and 100%, respectively.
Conclusions. In children, certain symptoms and signs that occur during the first several months following shunt inser­
tion are strongly associated with shunt failure; however, the individual absence of these symptoms and signs offers the 
clinician only a limited ability to rule out a shunt malfunction. Combining them in a weighted scoring system improves 
the ability to predict shunt failure based on clinical findings.
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E v a l u a t i o n  of patients with possible CSF shunt fail­
ure is a common practice in pediatric neurosurgery, 
given the 39% 1-year and 53% 2-year failure rates 
that have been observed following initial shunt place- 
ment.5 Predictive values for the signs and symptoms of 
shunt failure are important in deciding which patient 
should undergo an imaging study and/or should be trans­
ferred to a facility with neurosurgical expertise. Likewise, 
recognition of clinical factors that correlate with a low 
probability of shunt failure could simplify management.
A number of prior publications have addressed the use 
of CT scanning, magnetic resonance imaging, radionu­
cleotide, or iodinated contrast studies; shunt taps; Dop-
Abbreviations used in this paper: CI = confidence interval; 
CSF = cerebrospinal fluid; CT = computerized tomography; 
LOC = level of consciousness; LR = likelihood ratio; NPV = nega­
tive predictive value; PPV = positive predictive value; PSDT = Pe­
diatric Shunt Design Trial; ROC = receiver-operating characteristic.
pler ultrasonography; and intracranial pressure monitoring 
to aid in the diagnosis of patients with shunt malfunc- 
tion.3'7'9'131416'21'26-28 Fewer studies have concentrated on the 
symptoms and signs of shunt malfunction that are avail­
able from the history compilations and physical exami­
nations in such patients, and most of these are descrip- 
tive.1,6,10,12,24 Predictive values that can be used to estimate 
the likelihood of malfunction in the presence or absence of 
a clinical finding22 are very informative, but are consid­
ered more rarely. Watkins and colleagues29 and Piatt19,20 
evaluated the predictive value of clinical findings, con­
centrating on one or two symptoms, signs, or results of 
diagnostic studies. The clinician, however, is simultane­
ously presented with a number of these factors from which 
to shape impressions as to the likelihood of shunt failure. 
To assess the predictive ability of the clinical presentation 
of patients with possible shunt malfunction, we evaluated 
data collected during the PSDT. Our goal was to deter­
mine predictive values for individual symptoms and signs
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and, if possible, to identify combinations of these that 
might improve predictive ability.
Clinical Material and Methods
Pediatric Shunt Design Trial
Data were derived from the PSDT. In this trial, 344 
children with newly diagnosed hydrocephalus were ran­
domized into groups to receive one of three types of 
shunt valves (a standard differential pressure valve, a Del­
ta Valve [PS Medical-Medtronic, Goletta, CA], or a Sig­
ma Valve [Cordis, Miami, FL]) and were followed for a 
minimum of 1 year. Follow-up examinations were per­
formed at 3, 12, 24, and 36 months after shunt insertion, 
as well as whenever clinically indicated. The details of the 
study protocol of this prospective multicenter randomized 
controlled trial have been published elsewhere.4 At each 
follow-up visit, symptoms, signs, and test results were re­
corded in detail. Data forms, clinical notes, and results 
of imaging studies were forwarded to the trial methodolo­
gy center. Shunt function or failure was determined by the 
evaluating surgeon based on standardized criteria and was 
reviewed by an adjudication committee blinded to the ran­
domization status of the patient.
Definitions and Exclusions
In the primary analysis of the PSDT, the presence or ab­
sence of shunt failure was assessed using all available in­
formation including symptoms, signs, and results of imag­
ing studies. In some cases the symptoms and/or signs were 
the determining factors in the assessment of whether there 
was shunt failure and, rarely, they were the sole basis for 
the decision (if imaging study results were unavailable). 
For example, if a child presented with ventricles that had 
failed to decrease in size compared with findings of the 
preoperative study, the determination of the status of the 
shunt at that particular visit depended solely on the pres­
ence or absence of symptoms and signs. In the present 
study we excluded such cases and based our analysis on 
those patients for whom objective measures of shunt func­
tion were available. For this analysis a diagnosis of shunt 
failure was given if at least one of the following condi­
tions was present: 1) obstruction—ventricular enlarge­
ment compared with results of a baseline study, obvious 
migration or disruption of the catheter system demonstrat­
ed on an imaging study, or an obvious persistent CSF leak 
from the wound; 2) overdrainage—the presence of subdu­
ral fluid collections revealed on an imaging study; 3) loc- 
ulation—the presence of new, loculated compartments 
within the ventricular system; and 4) infection—a positive 
CSF culture, purulent discharge from the wound, or ero­
sion of the shunt system.
Shunt success was defined during the early postopera­
tive period ( 5 months after shunt insertion) as a de­
crease in ventricle size compared with results of a previ­
ous imaging study along with the lack of any features 
meeting the definition of shunt failure. During later follow 
up ( 9 months after shunt insertion), stable ventricle size 
(unchanged from a study in which researchers had previ­
ously documented decreased ventricle size) was accepted 
as proof of adequate shunt function. If no imaging study 
had been performed at the particular follow-up visit, but a
subsequent study demonstrated smaller ventricles, or if 
the patient had no evidence of shunt failure for more than
1 year after the time of the particular visit, this was accept­
ed as sufficient evidence of shunt function at the time of 
that visit.
Data Collection
We reviewed each patient encounter to assess whether 
the patient met the criteria of shunt failure or success at 
each visit. Ventricular size comparisons were made using 
a measured frontal/occipital horn ratio.17 In some cases in 
which these measurements were not available, the study 
clinician’s judgment concerning results demonstrated on 
imaging (same, larger, or smaller ventricle size) was ac­
cepted. If no determination could be made, the encounter 
was excluded from consideration.
Because it is recognized that the clinical presentation of 
shunt failure is different for patients in whom shunt inser­
tion was performed recently than for those in whom it was 
performed longer ago, we divided the follow-up visits in­
to two epochs.11,18 Early encounters included those visits 
occurring within the first 5 months following shunt in­
sertion, and were clustered mostly around the planned 
3-month follow-up visit. Late encounters included visits 
occurring 9 months or more after the time of shunt inser­
tion, and were clustered mostly around the planned 1-year 
follow-up visit. In cases in which duplicate visits occurred 
within the same period, only the first visit was included.
Statistical Analysis
Occurrences of particular symptoms and signs were 
tabulated against the fate of the shunt at each visit to cal­
culate sensitivity, specificity, PPVs, NPVs, LRs, and asso­
ciated CIs.25,30 The PPV represents the percentage of those 
patients presenting with a particular symptom who, in 
fact, have a shunt failure. The NPV is the percentage of 
those patients without a particular symptom who do not, 
in fact, have a shunt failure. The quantity 1 NPV gives 
the percentage of patients who, despite absence of the 
symptom, nevertheless have a shunt failure. Likelihood 
ratios express the odds that a symptom is present in a pa­
tient with shunt failure compared with its presence in a pa­
tient without shunt failure.22
To assess the ability of a combination of symptoms and 
signs to improve prediction of shunt success or failure, the 
encounters with patients were randomly divided into two 
sets, a derivation set for developing the model and a vali­
dation set for testing the model. Using only the derivation 
set of encounters, factors identified on the basis of a uni­
variate analysis and clinical experience were entered into 
a multivariate logistic regression model to identify inde­
pendent predictors of outcome and to develop a regression 
model. The coefficients from the model were then as­
signed as weights to the predictive factors.2 Whenever 
necessary, recursive partitioning methods were used to 
improve the efficacy of the developed model.15 For each 
patient encounter, a total shunt score was calculated as the 
sum of the weighting factors for each symptom and sign 
present. Data obtained in patients with clinical factors that 
appeared only in cases of shunt failure were excluded 
from the regression analysis to avoid destabilizing the re­
gression model, but these clinical factors were included in
J. Neurosurg. /  Volume 94 /  February, 2001 203
H. J. L. Garton, J. R. W. Kestle, and J. M. Drake
TABLE 1




no. of patients followed up in PSDT 344* 189t
not seen during interval or no follow-up form 44 7
evaluated patients 300 182
excluded patients 24 27
survival by absence of symptoms & signs alone 7 8
no imaging studies & unable to confirm survival
1 yr 5 18
failure based on symptoms alone 12 1
successful shunts 203 137
ventricles smaller (measured) 128 62
ventricles smaller (clinician’s report) 58 16
no image obtained, ventricle smaller on later image 14 7
clinically stable for >1 yr after visit 3 10
stable on scan after prior reduction 0 42
failed shunts 73 18
ventricles larger (measured) 11 5
ventricles larger (clinician’s report) 15 8
migration/malposition/ di sruption 13 2
CSF leak 1 0
overdrainage/subdural fluid collection 7 3
loculation (independent of larger ventricles) 1 0
infection 25 0
* Original cohort in the trial.
t  Members of original cohort remaining in trial after 9 months of fol­
low up.
the developed shunt score with an assigned weight. Colin- 
ear variables, as observed for some symptoms and signs of 
infection, were simplified to a single representative factor. 
The logistic regression analysis was performed using a 
forward conditional method with an entry level of signifi­
cance of 0.05. Goodness of fit of the logistic regression 
was tested using the Hosmer-Lemeshow statistic. Statisti­
cal analysis was performed using commercially available 
statistical computer software (SPSS, version 8.0 for Win­
dows; SPSS, Inc., Chicago, IL).
The validity of the scoring system was assessed by 
comparing shunt failure rates for each level of the total 
shunt score in the validation set of encounters. The reli­
ability of the model was determined by comparing the 
scoring system’s predictive properties in the two datasets, 
whereas the discriminatory power of the model was as­
sessed using ROC curve analysis to calculate the area un­
der the curve and associated CIs. The analytical protocol 
was repeated for both early and late encounter groups.
Results
During the early period, by applying the objective defi­
nition of shunt failure we were able to assess data in 300 
of the 344 patients who had initially been randomized. 
During this interval, in 44 patients either no encounter 
occurred or no follow-up form was obtained at the time 
of shunt failure. Of the 300 patients who were evaluated, 
24 patients had to be excluded because the fates of their 
shunts had been determined exclusively or primarily on 
the basis of presenting symptoms and signs. Of the re­
maining 276 patients, shunts were functioning in 203 and
had failed in 73. On average, therefore, children present­
ing for evaluation had a 26% chance of shunt failure.
During the late period, among the 189 patients in the 
trial whose shunts functioned longer than 9 months, there 
were no follow-up data forms for seven patients and shunt 
fate could not be confirmed by objective criteria in 27 pa­
tients. In the remaining 155 patients, there were 137 suc­
cessful shunts and 18 failed shunts, for a 12% failure rate 
(Table 1).
Clinical Characteristics
The study population consisted principally of very 
young children, which is not surprising given the require­
ment that participants had to have undergone their first 
shunt placement. For the group of early encounters, the 
median patient age at the visit, correcting for prematurity, 
was 143 days (4.6 months) and the mean ± standard de­
viation was 610 ± 1180 days. The median patient age at 
the visit in the late encounter group was 502 days (16.5 
months) and the mean ± standard deviation was 897 ± 
1056 days. The clinical features of patients participating 
in this analysis are presented in Table 2. In this table, pa­
tient age at the visit has been dichotomized to older or 
younger than 15 months to assist in assessing the preva­
lence of age-specific symptoms such as headache, fonta- 
nelle tension, and school performance.
During the early patient encounters, among the routine­
ly assessed symptoms, nausea and vomiting, irritability, 
bulging fontanelle, and increased head circumference all 
occurred at rates exceeding 10%. School performance was 
assessed less frequently in this group, which was expect­
ed given the age distribution of the patients. Surgeons in 
the trial assessed shunt valve performance (based on the 
questions “Was the shunt reservoir depressable?” and 
“Did it refill?”) in only approximately 50% of the visits 
because of variations in examination procedures or shunt 
valve design or both. During late patient encounters, 
symptoms and signs were generally less prevalent. 
Among routinely assessed symptoms only nausea and 
vomiting, headache, irritability, and increased head cir­
cumference occurred at rates of approximately 5% or 
more, whereas assessment of school performance and 
valve function were reported less commonly.
Predictive Values
In the early encounter group (Table 3), irritability and 
nausea and vomiting were associated with PPVs greater 
than 70%. Among clinical signs, several occurred only in 
patients with failing shunts, and there were no false-posi­
tive occurrences. These included decreased LOC in seven 
patients, papilledema in two, erythema around the shunt in 
seven, and peritonitis in four, as well as several other fea­
tures typical of infection. For these factors, the PPV was 
100% and the LR could not be calculated. Similarly, bulg­
ing fontanelle and fluid tracking around the shunt were 
highly predictive of shunt failure. Fever (PPV 89%) was 
also highly predictive of failure and in each instance oc­
curred in the infection category. No factors were individ­
ually successful in predicting the absence of shunt failure. 
The probability of a shunt malfunction, even when a par­
ticular symptom was absent (1 -  NPV), ranged from 17
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TABLE 2
Characteristics o f  postop encounters*
Clinical Parameter
No. of Encounters (%)
Early Encounter Group Late Encounter Group
no. of patients 276 155
patient age at visit
15 mos 216 (78.0) 62 (40.0)
15 mos 60 (28.0) 93 (60.0)
cause of hydrocephalus
IVH 67 (24.3) 48 (31.0)
MMC 56 (20.3) 21 (13.5)
tumor 25 (9.1) 15 (9.7)
AS 19 (6.9) 10 (6.5)
unknown & other 109 (39.5) 61 (39.4)
presenting symptom or sign
nausea & vomiting 33 of 274 (12.0) 7 of 154 (4.5)
headache 14 of 232 (6.0) 9 of 149 (6.0)
irritability 36 of 274 (13.1) 8 of 154 (5.2)
LDM 10 of 257 (3.9) 6 of 150 (4.0)
worsening of SP 2 of 190 (1.1) 1 of 111 (0.9)
new or changed seizures 7 of 271 (2.6) 4 of 152 (2.6)
bulging fontanelle 39 of 267 (14.6) 0 of 123 (0.0)
decreased LOC 7 of 272 (2.6) 2 of 153 (1.3)
papilledema 2 of 221 (0.9) 1 of 132 (0.8)
fluid tracking around shunt 20 of 275 (7.3) 3 of 154 (1.9)
sixth cranial nerve palsy 5 of 270 (1.9) 2 of 154 (1.3)
loss of upgaze 6 of 267 (2.2) 0 of 152 (0.0)
unable to depress reservoir 5 of 152 (3.3) 1 of 56 (1.8)
reservoir does not refill 7 of 151 (4.6) 4 of 56 (7.1)
increased head circumference 45 of 250 (18.0) 15 of 128 (11.7)
abdominal pain 5 of 274 (1.8) 0 of 155 (0.0)
nuchal rigidity 2 of 269 (0.7) 0 of 155 (0.0)
erythema 7 of 276 (2.5) 0 of 155 (0.0)
abdominal mass 1 of 274 (0.4) 0 of 155 (0.0)
meningismus 2 of 275 (0.7) 0 of 155 (0.0)
peritonitis 4 of 274 (1.5) 0 of 155 (0.0)
fever 19 of 276 (6.9) 1 of 155 (0.6)
* The early encounter group encompasses patients whose follow-up visits occurred less than 5 months after shunt placement, and the 
late encounter group includes patients whose follow-up visits occurred more than 9 months after shunt placement. Numbers of patients 
for whom yes/no answer was available are given; data for remaining patients were either not reported or reported as unknown. Abbre­
viations: AS = aqueductal stenosis; IVH = intraventricular hemorrhage; LDM = loss of developmental milestones; MMC = myelome­
ningocele; SP = school performance.
to 20%, an insufficient reduction from the baseline 26% 
failure rate.
In the late encounter group (Table 3), fewer symptoms 
and signs were predictive of outcome. Among factors oc­
curring more than once, only loss of developmental mile­
stones and decreased LOC had predictive values for fail­
ure that were higher than 70%. Again, even in the absence 
of a particular symptom or sign, there remained roughly a
10 to 14% chance of shunt failure, offering little discrim­
ination from the 12% baseline rate.
Regression Analysis
Early Encounter Group. In the derivation subset of 159 
patients (Table 4), symptoms and signs significantly asso­
ciated with shunt failure (p <  0.05) in the univariate 
assessment included decreased LOC, irritability, bulg­
ing fontanelle, headache, fever, nausea and vomiting, in­
creased head circumference, and fluid tracking around 
the shunt. Erythema, meningismus, abdominal pain, and 
peritonitis were also strongly statistically associated with
shunt failure, although meningismus, abdominal pain, and 
peritonitis occurred only when erythema was also pres­
ent, rendering these variables colinear with erythema and, 
thus, excluded from further analysis. Patients with de­
creased LOC and/or erythema always experienced shunt 
failures, and, thus, these clinical factors were included in 
the shunt score with an arbitrary weighting factor of 3. 
The remaining factors significant in the univariate analy­
sis were entered into the logistic regression analysis: irri­
tability, bulging fontanelle, headache, fever, nausea and 
vomiting, increased head circumference, and fluid track­
ing around the shunt. Also included were the clinically 
chosen variables: patient age at visit (as a continuous vari­
able), cause of hydrocephalus, and valve type. Irritability, 
bulging fontanelle, fever, headache, and fluid tracking 
around the shunt were all independent predictors, where­
as patient age, cause of hydrocephalus, and valve type did 
not significantly influence the associations. Whenever it 
could be calculated, the logistic regression model had an 
excellent goodness of fit (Hosmer-Lemeshow test: 2 = 
0.0038, p = 0.9981 [four of 10 deciles calculable]). These
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TABLE 3












Value 95% CI Ratio 95% CI TP FP FN TN
early encounter group
nausea & vomiting 79 61-91 19 10.4 4.7-23.0 0.7 36 97 26 7 46 195
headache 57 29-82 21 4.4 1.6-12.1 0.9 15 97 8 6 46 172
irritability 78 61-90 18 9.8 4.7-20.5 0.6 39 96 28 8 44 194
LDM 20 3-56 25 0.8 0.2-3.5 1.0 3 96 2 8 62 185
worsening of SP 50 1-99 29 2.4 0.2-37.6 1.0 2 99 1 1 55 133
new or changed seizures 0 0-41 27 0.0 — 1.0 0 96 0 7 72 192
bulging fontanelle 92 79-98 15 33.1 10.5-104.2 0.5 51 98 36 3 35 193
decreased LOC 100 59-100 25 NR — 0.9 10 100 7 0 66 199
papilledema 100 16-100 27 NR — 1.0 3 100 2 0 59 160
fluid tracking around shunt 75 51-91 23 8.3 3.1-22.0 0.8 21 98 15 5 58 197
sixth cranial nerve palsy 40 5-85 25 1.9 0.3-11.4 1.0 3 99 2 3 67 198
loss of upgaze 50 12-88 24 3.0 0.6-14.7 1.0 5 99 3 3 63 198
unable to depress reservoir 80 28-99 21 13.4 1.5-115.8 0.9 11 99 4 1 31 116
reservoir does not refill 86 42-100 20 19.9 2.5-159.7 0.8 17 99 6 1 29 115
increased head circumference 67 51-80 17 5.7 3.3-9.9 0.6 46 92 30 15 35 170
abdominal pain 100 48-100 25 NR — 0.9 7 100 5 0 68 201
nuchal rigidity 50 1-99 26 2.8 0.2-44.8 1.0 1 99 1 1 69 198
erythema 100 59-100 25 NR — 0.9 10 100 7 0 66 203
abdominal mass (pseudocyst) 100 2-100 26 NR — 1.0 1 100 1 0 72 201
meningismus 100 16-100 26 NR — 1.0 3 100 2 0 70 203
peritonitis 100 40-100 26 NR — 0.9 5 100 4 0 69 201
fever 89 67-99 22 23.6 5.6-99.8 0.8 23 99 17 2 56 201
late encounter group
nausea & vomiting 43 10-82 10 5.7 1.4-23.3 0.9 17 97 3 4 15 132
headache 22 3-60 11 2.2 0.5-9.8 0.9 12 95 2 7 15 125
irritability 25 3-65 11 2.5 0.5-11.5 0.9 11 96 2 6 16 130
LDM 83 36-100 9 36.7 4.5-296.4 0.7 28 99 5 1 13 131
worsening of SP 100 2-100 13 NR — 0.9 7 100 1 0 14 96
new or changed seizures 0 0-60 12 NR — 1.0 0 97 0 4 18 130
bulging fontanelle 0 — 11 NR — 1.0 0 100 0 0 13 110
decreased LOC 100 16-100 11 NR — 0.9 11 100 2 0 16 135
papilledema 100 2-100 12 NR — 0.9 6 100 1 0 16 115
fluid tracking around shunt 33 1-91 11 3.8 0.4-39.6 1.0 6 99 1 2 17 134
sixth cranial nerve palsy 50 1-99 11 7.6 0.5-115.6 1.0 6 99 1 1 17 135
loss of upgaze 0 — 12 NR — 1.0 0 100 0 0 18 134
unable to depress reservoir 100 2-100 11 NR — 0.9 14 100 1 0 6 49
reservoir does not refill 50 7-93 10 7.0 1.2-42.0 0.7 29 96 2 2 5 47
increased head circumference 27 8-55 10 2.7 1.0-7.5 0.8 27 90 4 11 11 102
abdominal pain 0 — 12 NR — 1.0 0 100 0 0 18 137
nuchal rigidity 0 — 12 NR — 1.0 0 100 0 0 18 137
erythema 0 — 12 NR — 1.0 0 100 0 0 18 137
abdominal mass (pseudocyst) 0 — 12 NR — 1.0 0 100 0 0 18 137
meningismus 0 — 12 NR — 1.0 0 100 0 0 18 137
peritonitis 0 — 12 NR — 1.0 0 100 0 0 18 137
fever 0 0-98 12 NR — 1.0 0 99 0 1 18 136
* LR = likelihood ratio for shunt failure in presence of symptom; LR Neg = likelihood ratio for shunt failure in absence of symptom; NR = no result, divi­
sion by zero; —  = not applicable.
t  Number of encounters in which there were false-negative (FN), false-positive (FP), true-negative (TN), and true-positive (TP) results.
five symptoms and signs were assigned weights based on 
their regression coefficients (Table 5). Summing these 
weights as well as those for decreased LOC and erythema 
for each symptom or sign present at a patient encounter, 
the clinical scores ranged from 0 to 8 in the derivation set. 
For example, a child with a decreased LOC and a bulging 
fontanelle scored a 3 + 2 = 5 total score (Table 5).
In the validation set of 118 patients, the overall risk of 
shunt failure was 28%. The risks of shunt failure associat­
ed with scores of 0, 1, 2, or 3 or more were 4% (three of 
79), 50% (five of 10), 75% (nine of 12), and 100% (15 of
15), respectively. The ROC curve analysis demonstrated a 
high degree of homology between the derivation and vali­
dation sets, with the area under the curve equal to 0.95 
(95% CI 0.92-0.99) for the derivation set and 0.93 (95% 
CI 0.88-0.98) for the validation set (Fig. 1).
Late Encounter Group. In the derivation subset of 100 
patients, loss of developmental milestones and nausea and 
vomiting were the only variables significantly associated 
with shunt failure (Table 4). In the logistic regression anal­
ysis, which included these factors and patient age at visit,
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TABLE 4
Results of univariate analysis, derivation set only, in the early and late encounter groups
Clinical Parameter
No. of Shunt Failures No. of Shunt Survivals Odds Ratio
p Value MA Status*Present Assessed Present Assessed Ratio 95% CI
early encounter group
nausea & vomiting 17 41 5 118 16.0 5.3-47.6 0.000 I
headache 7 30 3 108 10.6 2.5-44.3 0.001 I
irritability 17 40 6 118 13.8 4.9-38.7 0.000 I
LDM 1 33 5 114 0.7 0.1-6.0 1.000 —
worsening of SP 1 29 1 82 2.9 0.2-47.8 0.456 —
new or changed seizures 0 40 4 117 0.0 — 0.573 —
bulging fontanelle 20 40 1 107 106.0 13.5-835.4 0.000 I
decreased LOC 4 41 0 116 — — 0.004 E
papilledema 1 34 0 98 — — 0.258 —
fluid tracking around shunt 7 41 4 118 5.9 1.6-21.3 0.009 I
sixth cranial nerve palsy 1 38 2 118 1.6 0.2-17.8 0.570 —
loss of upgaze 1 35 1 118 3.4 0.2-56.5 0.406 —
unable to depress reservoir 1 16 1 69 4.5 0.3-76.6 0.343 —
reservoir does not refill 2 17 1 68 8.9 0.7-105.1 0.101 —
increased head circumference 17 37 9 110 9.5 3.7-24.4 0.000 I
abdominal pain 4 41 0 117 — — 0.004 E
nuchal rigidity 1 38 1 115 3.1 0.2-50.5 0.436 —
erythema 4 41 0 118 — — 0.004 E
abdominal mass (pseudocyst) 1 41 0 117 — — 0.259 —
meningismus 2 40 0 118 — — 0.063 —
peritonitis 3 41 0 117 — — 0.017 E
fever 9 41 1 118 32.9 4.0-269.4 0.000 I
late encounter group
nausea & vomiting 2 11 1 89 19.6 1.6-237.4 0.031 I
headache 1 10 5 87 1.8 0.2-17.4 0.489 —
irritability 1 11 3 88 2.8 0.3-29.9 0.377 —
LDM 3 11 1 86 31.9 3.0-343.2 0.004 I
worsening of SP 1 8 0 64 — — 0.111 —
new or changed seizures 0 11 4 87 0.0 — 1.000 —
bulging fontanelle 0 9 0 74 — — — —
decreased LOC 1 11 0 88 — — 0.111 —
papilledema 0 10 0 77 — — — —
fluid tracking around shunt 1 11 1 89 8.8 0.5-151.8 0.209 —
sixth cranial nerve palsy 0 11 0 89 — — — —
loss of upgaze 0 11 0 87 — — — —
unable to depress reservoir 1 5 0 33 — — 0.132 —
reservoir does not refill 1 5 2 33 3.9 0.3-53.1 0.353 —
increased head circumference 3 10 10 73 2.7 0.6-12.2 0.187 —
abdominal pain 0 11 0 89 — — — —
nuchal rigidity 0 11 0 89 — — — —
erythema 0 11 0 89 — — — —
abdominal mass (pseudocyst) 0 11 0 89 — — — —
meningismus 0 11 0 89 — — — —
peritonitis 0 11 0 89 — — — —
fever 0 11 1 89 0.0 — 0.724 —
* Status of variable in multivariate analysis (MA); E = excluded from the multivariate analysis because 100% predictive or always encountered with find­
ing also excluded from multivariate regression; I = included in multivariate regression. See Regression Analysis for full explanation.
73% of the shunt failures were associated with scores 
higher than 0.
In the validation set of 55 patients, the risks of shunt 
failure associated with scores of 0, 1, or 2 or more were 
8% (three of 46), 38% (three of eight), and 100% (one of 
one), respectively. The ROC curve analysis again demon­
strated a high degree of homology between derivation and 
validation sets, with the area under the curve equal to 0.8 
(95% CI 0.68-0.92) for the derivation set and 0.74 (95% 
Ci 0.58-0.9) for the validation set (Fig. 1).
Sensitivity Assessment
Because of the risk of a missed diagnosis and to identi-
cause of hydrocephalus, and shunt valve type, both symp­
toms remained independently associated with shunt fail­
ure, whereas patient age, cause of hydrocephalus, and 
shunt valve type did not influence the association. How­
ever, the scoring system, in which a weight of 1 was as­
signed to each symptom and a cut point of greater than 0 
indicated shunt failure, detected only 54% of the shunt 
failures (that is, with a score 0). Based on recursive par­
titioning methods and clinical judgment the following fac­
tors were added: decreased LOC (assigned weight of 3), 
fluid tracking around the shunt (weight of 1), and in­
creased head circumference (weight of 1) (Table 5). Clin­
ical scores ranged from 0 to 4 in the derivation set, and
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TABLE 5
Multivariate analysis and symptom score*
Variable Coefficientt SE OR (95% CI) p Value Weighty
early encounter group
fluid tracking around shunt 2.61 1.29 13.6 (1.1-173.2) 0.0443 1
headache 3.57 1.145 35.8 (3.8-339.3) 0.0018 1
irritability 3.80 0.929 44.6 (7.2-275.5) 0.001 1
fever 4.70 1.392 110.3 (7.2-275.5) 0.001 1
bulging fontanelle 6.08 1.262 439.4 (37.0-5216.1) 0.001 2
erythema — — — — 3
decreased LOC — — — — 3
late encounter group
nausea & vomiting 3.37 1.30 29.0 (2.2-367.2) 0.009 1
LDM 3.77 1.23 43.4 (3.9-484.0) 0.002 1
increased head circumference — — — — 1
fluid tracking around shunt — — — — 1
decreased LOC — — — — 3
* OR = odds ratio; SE = standard error of the coefficient.
t  The coefficient, which was determined by logistic regression, represents the increase in the log of the odds of shunt failure for the 
presence or absence of a given symptom while holding all other variables constant.
t  Each coefficient was divided by 2.61 and rounded down to the nearest whole number. A patient’s total score is determined by sum­
ming the weights for each symptom present. Therefore, a patient presenting during the first 5 months after shunt insertion with a 
bulging fontanelle and fluid tracking around the shunt would have a score of 1 2 = 3.
fy limitations in the scoring system, we assessed its sensi­
tivity for shunt failure across the entire dataset. Based on 
the ROC curve, a score of 1 or more was chosen to predict 
shunt failure. In the early group, five (7%) of 73 patients 
with failures had symptom scores of 0 and true shunt sta­
tus would not have been detected by the scoring system. 
Two of these patients had increased head circumference 
and in one the shunt reservoir could not be depressed. The 
other two patients had no recorded symptoms or signs. In 
one of them loculated ventricles and in the other a sub­
dural effusion were revealed on CT scans at the time of 
the follow-up visits.
Performance in the late encounter group was not as 
good. Again for the entire dataset, six (33%) of the 18 pa­
tients with shunt failures had scores of 0. One patient had 
a headache and in another there was no refilling of the 
shunt reservoir. In the remaining four patients no symp­
toms or signs were identified, but the shunt was shown to 
have failed on the basis of increased ventricle size.
Discussion
In this study, follow-up data collected during the PSDT 
were used to determine the incidence and predictive val­
ues of individual symptoms and signs of shunt malfunc­
tion and to find a combination of those most effective for 
predicting malfunction.
Our data demonstrate that the common symptoms of 
shunt malfunction are indeed strongly predictive of shunt 
failure during the early period following shunt insertion, 
which we arbitrarily defined as less than 5 months after 
shunt insertion. Some factors, specifically decreased LOC 
and erythema around the wound, were always indicative 
of shunt failure (either obstruction or infection). In the 
late encounter group, arbitrarily defined as longer than 9 
months after insertion, clinical factors were less predictive 
of failure, which coincides with a reduction in the rate of 
shunt failure. The predictive values determined in this
analysis are generally higher than those reported by Wat­
kins and colleagues.29 Over a 5-month period those re­
searchers studied 52 admissions (45 patients) to their insti­
tution in which the patients presented with a tentative 
diagnosis of shunt malfunction. In 19 (36%) of these hos­
pital admissions, the patients were found in fact to have 
shunt malfunction. Assuming that at all admissions their 
patients were evaluated for all symptoms, the predictive 
values for the clinical features of malfunction were as fol­
lows: headache, PPV 30% (nine of 30), LR 0.74; irritabil­
ity, PPV 47% (seven of 15), LR 1.51; decreased LOC, 
PPV 85% (11 of 13), LR 9.5; vomiting, PPV 36% (10 of 
28), LR 1.2; and temperature, PPV 22% (two of nine), LR 
0.49. These values are closer to those found in our later 
encounter group (Table 3). Decreased LOC was the factor 
most strongly predictive of failure in both their study and 
our early encounter group. The difference seen in prog­
nostic values may be due to differences in the study 
populations, end point definitions, or methods of data col­
lection.
Particular symptoms and signs have attracted attention 
in the literature. A number of authors have commented on 
the association or lack thereof between seizures and shunt 
malfunction. Although epilepsy is common in children 
with hydrocephalus, the literature indicates that seizures 
are rarely a presenting symptom in cases of shunt fail- 
ure.6'810'23'24 In the PSDT, seizures were a presenting symp­
tom in only approximately 2.6% of the encounters. John­
son and colleagues10 noted that 16 of 544 emergency 
encounters with patients with seizure disorders and shunt­
ed hydrocephalus culminated in shunt revisions. This 
yields a predictive value of 2.9%. In our study, in none of 
the 11 encounters in which seizures occurred was a shunt 
failure actually present, although the small number of pa­
tients presenting with seizures limits the strength of any 
conclusion based on this.
Piatt19 evaluated the usefulness of “pumping the shunt” 
in determining the likelihood of malfunction and noted a 
sensitivity of 18 to 20% and a specificity of 63 to 93%. In
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our analysis, considering the early encounter group, sensi­
tivity was similar (11% for reservoir depression and 17% 
for reservoir refill); however, specificity was higher (99%) 
for the two parameters, meaning that there were very few 
false-positive test results. As a result the PPV for the res­
ervoir failing to depress or refill was much higher in our 
study than in Piatt’s study (80-86% compared with 17­
21%). The predictive value of the absence of abnormality 
indicating shunt patency (NPV) was similar (79-80% 
compared with 65-81%). The patients in Piatt’s study 
were older (median age 87 months) and had a lower over­
all shunt failure rate (14%). Our evaluation of this clinical 
sign in relation to others was limited by a lack of reports 
among a substantial number of patients, either because the 
information was not obtainable or because individual clin­
ical practice did not include the assessment.
Ashkenazi and colleagues1 reported a case series of 15 
patients presenting with fever as the first sign of shunt 
malfunction, but did not provide sufficient information to 
determine the sign’s predictive value. Watkins, et al.,29 re­
ported that fever was slightly protective and its presence 
lowered the probability of a shunt failure (overall rate of 
failure 36%, rate of failure associated with fever 22%). 
However, none of their patients suffered from shunt in­
fection. In our study population, fever was not associated 
with shunt failure in the absence of infection, but occurred 
in 17 of 25 patients with infection in the early encounter 
group, raising the predictive value for shunt failure to the 
89% reported in Table 3.
It would have been desirable to compare overall failure 
rates and predictive values in patients examined during 
routine follow-up visits compared with those seen on an 
emergency basis. However, the study data forms did not 
allow us accurately to distinguish the setting of the en­
counter.
Success o f  the Clinical Decision Rule
In attempting to rule out a shunt failure, the absence of 
an individual symptom did little to reduce the likelihood 
of shunt failure. By combining symptoms in a weighted 
scoring system, we improved our predictive ability. The 
presence of only one of several factors in the clinical scor­
ing system was associated with a high enough rate of 
shunt failure in either the early or late encounter group to 
justify liberal use of imaging studies in patients with such 
a presentation. The absence of all symptoms in the scor­
ing system produced a lower posttest probability of shunt 
failure, especially in the early encounter group, but not all 
shunt failures were detected by it. A number of these pa­
tients experienced ventricular enlargement without clini­
cal symptoms, highlighting the value of routine postoper­
ative imaging studies in this patient population. Whether 
such misclassifications would result in actual harm, or 
merely delay diagnosis, cannot be determined from this 
type of secondary data analysis. Nevertheless, we believe 
that misclassification rates of 7% and 33% for the early 
and late encounter groups, respectively, are too high, with­
out a clear understanding of their effects.
Limitations o f  the Study
Information gathered in rigorous clinical trials, such as 
that which has been used in this analysis, must be careful-
Fig. 1. Graphs demonstrating ROC curves for scoring systems. 
Comparisons between the derivation and validation sets are shown 
for both early and late encounter groups.
ly assessed for its relevance to the routine practice of med­
icine. If the predictive values seem above expectation, it 
must be remembered that the data were gathered on very 
young patients presenting to neurosurgeons for both rou­
tine and unscheduled follow-up examinations after a first 
shunt placement. Different providers, seeing a broader 
cross section of pediatric disease, might be expected to 
have a lower prevalence of children with shunt malfunc­
tion and, thus, lower predictive values for individual 
symptoms. However, the symptoms and signs themselves 
should retain their individual diagnostic properties (sensi­
tivity, specificity, and LR).
Despite the fact that we evaluated a relatively large 
number of total encounters for rare symptoms, the num­
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bers remained small for rare symptoms, producing wide 
CIs. Similarly, the combination of a smaller late encounter 
sample, due to prior shunt failures, and a reduction in the 
incidence of failures combined to reduce the number of 
shunt failures available for assessment in the late encoun­
ter group, with similar impact on the CIs.
Conclusions
Our analysis determined the predictive values of com­
mon symptoms and signs of shunt failure in very young 
children after their first shunt insertion. This was based on 
a secondary analysis of data from the recently completed 
PSDT. Individual symptoms and signs had high PPVs, but 
offered only limited ability effectively to rule out a shunt 
malfunction. Combining symptoms and signs to produce 
a weighted scoring system improved predictive ability. 
However, effectively ruling out the presence of a shunt 
malfunction remained problematic, particularly in the late 
encounter group. Using actual prevalence rates in the ear­
ly and late follow-up periods of 26% and 12%, respective­
ly, the likelihood of shunt malfunction in patients with a 
minimum shunt score was reduced to 4% and 8%, respec­
tively. However, when even a single symptom or sign 
from the scoring system was present, the probability of a 
shunt failure was approximately 40%, justifying the liber­
al use of imaging studies or other objective assessments of 
shunt function in these patients.
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